FDA Food recall F-2400-2014
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
- FDA Food
- Class II
- terminated
- Published 2014-09-03
On 2014-09-03 the FDA classified a Class II recall of PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802 by Beta Labs, citing the products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-2400-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-06-20 |
| Published | 2014-09-03 |
| Last updated | 2026-09-13 11:48 UTC |
| Company | Beta Labs |
| Distribution | US |
Product
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
Reason
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Identifiers
| upc | 029882559802 |
|---|---|
| code_info | Lot # 1205129, Exp 12/16 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:48 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-2400-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.